IL18 and inflammatory bowel disease: While levels of proinflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin (IL)-18, were elevated in the serum of IBD mice, these levels were further elevated by CRH treatment (Fig. 2A).